statistical software package instat and graphpad prism, version 4.0 (GraphPad Software Inc)
GraphPad Software Inc is a verified supplier 
90
Structured Review
GraphPad Software Inc
statistical software package instat and graphpad prism, version 4.0
Statistical Software Package Instat And Graphpad Prism, Version 4.0, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/statistical+software+package+instat+and+graphpad+prism%2C+version+4%2E0/instat+graphpad+prism+software+version+4+0/pm17429722-78-11-20
Average 90 stars, based on 1 article reviews
Statistical Software Package Instat And Graphpad Prism, Version 4.0, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/statistical+software+package+instat+and+graphpad+prism%2C+version+4%2E0/instat+graphpad+prism+software+version+4+0/pm17429722-78-11-20
Average 90 stars, based on 1 article reviews
statistical software package instat and graphpad prism, version 4.0 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Software:Article Title: Nimesulide alters cell recruitment into mitosis in murine intestinal crypts without influencing the cell production rate. Article Snippet: The use of nonsteroidal anti-inflammatory drugs (NSAIDs) that exhibit COX-2 selectivity is associated with fewer gastrointestinal side effects than seen with more traditional NSAIDs.. To determine whether the early effects on cell kinetics in the intestinal mucosal epithelium described after COX-2 selective inhibition are sustained following continuous therapy with these inhibitors, assessments of morphometry and cryptal cell proliferation in the murine small intestinal mucosa were made at 24 hr after treatment with indomethacin, a dual COX inhibitor (10 mg/kg body weight intraperitoneally), nimesulide, a selective COX-2 inhibitor (15 mg/kg body weight intraperitoneally), or vehicle.. Nimesulide-treated intestine was elongated beyond control values, in contrast to the shorter indomethacintreated intestine, but anomalous villous forms were present in both treated groups. |